0001181431-12-029998.txt : 20120515
0001181431-12-029998.hdr.sgml : 20120515
20120515171218
ACCESSION NUMBER: 0001181431-12-029998
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20120514
FILED AS OF DATE: 20120515
DATE AS OF CHANGE: 20120515
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Siegel Eric H.
CENTRAL INDEX KEY: 0001527573
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-12400
FILM NUMBER: 12845927
MAIL ADDRESS:
STREET 1: ROUTE 141 & HENRY CLAY RD., BLDG. E336
STREET 2: C/O INCYTE CORP., EXPERIMENTAL STATION
CITY: WILMINGTON
STATE: DE
ZIP: 19880
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: INCYTE CORP
CENTRAL INDEX KEY: 0000879169
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
IRS NUMBER: 943136539
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ROUTE 141 & HENRY CLAY ROAD
STREET 2: BUILDING E336
CITY: WILMINGTON
STATE: DE
ZIP: 19880
BUSINESS PHONE: 3024986700
MAIL ADDRESS:
STREET 1: ROUTE 141 & HENRY CLAY ROAD
STREET 2: BUILDING E336
CITY: WILMINGTON
STATE: DE
ZIP: 19880
FORMER COMPANY:
FORMER CONFORMED NAME: INCYTE CORP
DATE OF NAME CHANGE: 20030318
FORMER COMPANY:
FORMER CONFORMED NAME: INCYTE GENOMICS INC
DATE OF NAME CHANGE: 20000710
FORMER COMPANY:
FORMER CONFORMED NAME: INCYTE PHARMACEUTICALS INC
DATE OF NAME CHANGE: 19930902
4
1
rrd345262.xml
X0305
4
2012-05-14
0
0000879169
INCYTE CORP
INCY
0001527573
Siegel Eric H.
EXPERIMENTAL STATION
ROUTE 141 AND HENRY CLAY RD
WILMINGTON
DE
19880
0
1
0
0
EVP, General Counsel
Common Stock
2012-05-14
4
M
0
8002
16.66
A
8817
D
Common Stock
2012-05-14
4
M
0
31997
16.66
A
40814
D
Common Stock
2012-05-14
4
M
0
16667
14.72
A
57481
D
Common Stock
2012-05-14
4
S
0
56666
23.12
D
815
D
Common Stock
2012-05-14
4
S
0
100
23.12
D
715
D
Common Stock
2012-05-14
4
S
0
715
23.11
D
0
D
Incentive Stock Option (right to buy)
16.66
2012-05-14
4
M
0
8002
0
D
2017-10-28
Common Stock
8002
10004
D
Non-Qualified Stock Option (right to buy)
16.66
2012-05-14
4
M
0
31997
0
D
2017-10-28
Common Stock
31997
29997
D
Non-Qualified Stock Option (right to buy)
14.72
2012-05-14
4
M
0
16667
0
D
2018-01-24
Common Stock
16667
22221
D
Reporting person undertakes to provide upon request by the Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within the range indicated.
Represents weighted average sale price. Actual sale prices ranged from $23.05 to $23.15.
Beginning October 29, 2010, options become exercisable in 25 installments, with the first intallment of 33.33% vesting after one year and the remaining vesting monthly over two years.
Beginning January 25, 2011, options become exercisable in 25 installments, with the first intallment of 33.33% vesting after one year and the remaining vesting monthly over two years.
/s/ Eric Siegel
2012-05-15